It was aimed to investigate the factors affecting choice of renal replacement therapy by examining data patients with end stage disease, whom we applied a predialysis education program. Patients who were started on in our clinic evaluated retrospectively. Renal divided into three groups as hemodialysis, peritoneal dialysis and transplantation compared according their clinical demographic charac...

Several new medications are now available for immunosuppression in the kidney transplant field. Tacrolimus and mycophenolate mofetil were first introduced for immunosuppression in renal transplantation in the mid 1990s. Since then, the combination of tacrolimus and mycophenolate mofetil has been evaluated in numerous clinical trials. The outcomes of these trials have varied due to differences i...

Cystinosis, an autosomal recessive disorder of lysosomal cystine accumulation, results from mutations in the CTNS gene that encodes the lysosomal cystine transporter, cystinosin. Renal tubular Fanconi syndrome occurs in infancy, followed by rickets, growth retardation, photophobia, and renal failure, which requires renal transplantation at approximately 10 yr of age. Treatment with cysteamine d...

BACKGROUND In Rotterdam 304 heart transplants have been performed since 1984. End-stage renal failure, necessitating renal replacement therapy, has developed in 24 patients (8%) after an interval of 25-121 months (median 79 months). After starting renal replacement therapy one-year survival was only 60%. Overall survival after heart transplantation, however, was favourable: 5 and 10 year surviv...

Introduction Although the management of scleroderma continues to evolve, it is unknown whether the burden of end-stage kidney disease (ESKD) treated with maintenance renal replacement therapy from SD has changed. Methods We examined United States Renal Data System data (n = 1,677,303) for the years 1996 to 2012 to quantify the incidence and outcomes of ESKD from scleroderma treated with renal...

Calcineurin inhibitors remain an integral component of immunosuppressive therapy regimens following solid organ transplantation. Although nephrotoxicity associated with these agents is well documented, type IV renal tubular acidosis is a rare and potentially underreported complication following liver transplantation. Hepatologists must be able to recognize this adverse effect as it can lead to ...

enal replacement therapy for patients with ESRD includes several options, the main categories being renal transplantation, hemodialysis, and peritoneal dialysis. In this chapter hemodialysis (HD) is subdivided into center and home hemodialysis whereas peritoneal dialysis (PD) refers to predominantly continuous ambulatory PD (CAPD) and continuous cycling PD (CCPD) with a small subgroup of other ...

Although the incidence of end stage renal failure in patients with autoinflammatory diseases has decreased since the introduction of the interleukin-1 (IL-1)-receptor antagonist anakinra, it is still relatively common. Cessation of anti-IL-1 therapy during and after kidney transplantation will not be possible in most patients because of the risk of recurrence of inflammation. The effect of cont...

BACKGROUND Laparoscopy has been successfully used following renal transplantation for many procedures, including native kidney nephrectomy, revision of transplant ureters and cholecystectomy. Laparoscopic surgery has also been used recently to treat pelvic disorders in patients after renal transplantation, such as removal of endometriotic cyst and hysterectomy. In such cases, we must pay specia...

Hepato-renal syndrome (HRS) is a rare complication that may accompany end-stage cystic fibrosis-associated cirrhosis in patients with fibrosis. There currently no unified protocol for the diagnosis and treatment of HRS fibrosis, particularly pediatric patients. The main approaches to diagnosing condition are detect signs acute renal failure patient severe liver damage absence shock organic kidn...